TABLE 4.
Group | Normal | Model | SASP | LF-HFY06 |
T-SOD (U/mL) | 218 ± 11a | 127 ± 11b | 184 ± 19c | 198 ± 14c |
CAT (U/mL) | 57.6 ± 9.4a | 17.9 ± 3.6b | 43.2 ± 6.2c | 35.2 ± 3.9c |
MDA (nmol/mL) | 3.8 ± 1.0a | 13.1 ± 1.9b | 6.9 ± 0.5c | 6.8 ± 1.1c |
Values are presented as the mean ± standard deviation (n = 8/group). Normal, mice were treated with saline; Model, mice were treated with 5% DSS; SASP, mice were treated with 50 mg/mL of salicylazosulfapyridine + 5% DSS; LF-HFY06, mice were treated with 1.0 × 109 CFU/mL of LF-HFY06 + 5% DSS; a–csignificant difference (P < 0.05) was indicated by different letters in the same row after Tukey’s test.